Powder: -20°C for 3 years | In solvent: -80°C for 1 year
AG6033 is a potential novel CRBN modulator. AG6033 is able to modulate the interaction of CRBN with a variety of antitumor target proteins and exhibits inhibitory effects on a wide range of tumor cells. AG6033 is able to degrade GSPT1 and IKZF1 and induce CRBN-dependent cytotoxic effects.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | AG6033 is a potential novel CRBN modulator. AG6033 is able to modulate the interaction of CRBN with a variety of antitumor target proteins and exhibits inhibitory effects on a wide range of tumor cells. AG6033 is able to degrade GSPT1 and IKZF1 and induce CRBN-dependent cytotoxic effects. |
Molecular Weight | 517.53 |
Formula | C30H23N5O4 |
CAS No. | 329706-62-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
AG6033 329706-62-9 inhibitor inhibit